203 related articles for article (PubMed ID: 21484085)
1. Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer.
Künzli BM; Bernlochner MI; Rath S; Käser S; Csizmadia E; Enjyoji K; Cowan P; d'Apice A; Dwyer K; Rosenberg R; Perren A; Friess H; Maurer CA; Robson SC
Purinergic Signal; 2011 Jun; 7(2):231-41. PubMed ID: 21484085
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease.
Künzli BM; Berberat PO; Giese T; Csizmadia E; Kaczmarek E; Baker C; Halaceli I; Büchler MW; Friess H; Robson SC
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G223-30. PubMed ID: 16920697
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
4. Host CD39 Deficiency Affects Radiation-Induced Tumor Growth Delay and Aggravates Radiation-Induced Normal Tissue Toxicity.
Meyer AV; Klein D; de Leve S; Szymonowicz K; Stuschke M; Robson SC; Jendrossek V; Wirsdörfer F
Front Oncol; 2020; 10():554883. PubMed ID: 33194619
[TBL] [Abstract][Full Text] [Related]
5. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.
Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y
Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184
[TBL] [Abstract][Full Text] [Related]
6. Colorectal Cancer and Purinergic Signalling: An Overview.
Roliano GG; Azambuja JH; Brunetto VT; Butterfield HE; Kalil AN; Braganhol E
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230810
[TBL] [Abstract][Full Text] [Related]
7. CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice.
Sun X; Wu Y; Gao W; Enjyoji K; Csizmadia E; Müller CE; Murakami T; Robson SC
Gastroenterology; 2010 Sep; 139(3):1030-40. PubMed ID: 20546740
[TBL] [Abstract][Full Text] [Related]
8. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
9. Heightened NTPDase-1/CD39 expression and angiogenesis in radiation proctitis.
Sheth S; Bleibel W; Thukral C; A-Rahim Y; Beldi G; Csizmadia E; Robson SC
Purinergic Signal; 2009 Sep; 5(3):321-6. PubMed ID: 19337853
[TBL] [Abstract][Full Text] [Related]
10. Regulated catalysis of extracellular nucleotides by vascular CD39/ENTPD1 is required for liver regeneration.
Beldi G; Wu Y; Sun X; Imai M; Enjyoji K; Csizmadia E; Candinas D; Erb L; Robson SC
Gastroenterology; 2008 Nov; 135(5):1751-60. PubMed ID: 18804472
[TBL] [Abstract][Full Text] [Related]
11. Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer.
Schmid S; Kübler M; Korcan Ayata C; Lazar Z; Haager B; Hoßfeld M; Meyer A; Cicko S; Elze M; Wiesemann S; Zissel G; Passlick B; Idzko M
Lung Cancer; 2015 Dec; 90(3):516-21. PubMed ID: 26505137
[TBL] [Abstract][Full Text] [Related]
12. The role of NK cells and CD39 in the immunological control of tumor metastases.
Zhang H; Vijayan D; Li XY; Robson SC; Geetha N; Teng MWL; Smyth MJ
Oncoimmunology; 2019; 8(6):e1593809. PubMed ID: 31069159
[TBL] [Abstract][Full Text] [Related]
13. Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis.
Moret R; Hellmers L; Zhang X; Gills J; Hite N; Klinger A; Maresh GA; Canter D; Bardot S; Margolin DA; Li L
J Vis Exp; 2019 May; (147):. PubMed ID: 31132059
[TBL] [Abstract][Full Text] [Related]
14. Selective deletion of ENTPD1/CD39 in macrophages exacerbates biliary fibrosis in a mouse model of sclerosing cholangitis.
Rothweiler S; Feldbrügge L; Jiang ZG; Csizmadia E; Longhi MS; Vaid K; Enjyoji K; Popov YV; Robson SC
Purinergic Signal; 2019 Sep; 15(3):375-385. PubMed ID: 31243614
[TBL] [Abstract][Full Text] [Related]
15. Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/ENTPD1 null mice.
Sun X; Han L; Seth P; Bian S; Li L; Csizmadia E; Junger WG; Schmelzle M; Usheva A; Tapper EB; Baffy G; Sukhatme VP; Wu Y; Robson SC
Hepatology; 2013 Jan; 57(1):205-16. PubMed ID: 22859060
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses.
Shevchenko I; Mathes A; Groth C; Karakhanova S; Müller V; Utikal J; Werner J; Bazhin AV; Umansky V
Oncoimmunology; 2020 Apr; 9(1):1744946. PubMed ID: 33457090
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the expression and function of the P2X7 receptor and ART1 in human regulatory T-cell subsets.
Cortés-Garcia JD; López-López C; Cortez-Espinosa N; García-Hernández MH; Guzmán-Flores JM; Layseca-Espinosa E; Portales-Cervantes L; Portales-Pérez DP
Immunobiology; 2016 Jan; 221(1):84-93. PubMed ID: 26307000
[TBL] [Abstract][Full Text] [Related]
18. P2X7 Receptor Signaling Contributes to Sepsis-Associated Brain Dysfunction.
Savio LEB; Andrade MGJ; de Andrade Mello P; Santana PT; Moreira-Souza ACA; Kolling J; Longoni A; Feldbrügge L; Wu Y; Wyse ATS; Robson SC; Coutinho-Silva R
Mol Neurobiol; 2017 Oct; 54(8):6459-6470. PubMed ID: 27730511
[TBL] [Abstract][Full Text] [Related]
19. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC
Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325
[TBL] [Abstract][Full Text] [Related]
20. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
